TAK-536TCH
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-536TCH, covering 2017-06-26 to 2017-06-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension [Phase 3]